Correction: Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients
Crossref DOI link: https://doi.org/10.1038/s41408-020-00374-3
Published Online: 2020-11-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thiant, S.
Moutuou, M. M.
Laflamme, P.
Boumedine, R. Sidi
Leboeuf, D. M.
Busque, L.
Roy, J.
Guimond, M.
Text and Data Mining valid from 2020-11-04
Version of Record valid from 2020-11-04
Article History
First Online: 4 November 2020